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Abstract 31 
Purpose Wild blueberries (WB) (Vaccinium angustifolium) are rich sources of polyphenols such as flavonols, 32 
phenolic acids and anthocyanins (ACNs) suggested to decrease the risk of cardiovascular and degenerative 33 
diseases. This study investigated the effect of regular consumption of a WB drink or a placebo (PL) drink on 34 
markers of oxidative stress, inflammation and endothelial function in subjects with risk factors for cardiovascular 35 
diseases.  36 
Methods Eighteen male volunteers (ages 47.8  9.7 years; body mass index 24.8  2.6 kg/m2) received 37 
according to a cross-over design, a WB (25 g freeze-dried providing 375mg of ACNs) or PL drink for six weeks, 38 
spaced out by a 6 week wash-out. Endogenous and oxidatively induced DNA damage in mononuclear blood 39 
cells, serum interleukin levels, reactive hyperemia index, nitric oxide, soluble vascular adhesion molecule 40 
concentration and other variables were analyzed. 41 
Results Wild blueberry drink intake significantly reduced the levels of endogenously oxidized DNA bases (from 42 
12.5  5.6% to 9.6  3.5%, p0.01) and the levels of H2O2-induced DNA damage (from 45.8  7.9% to 37.2  43 
9.1%, p0.01), while no effect was found after the PL drink. No significant differences were detected for 44 
markers of endothelial function and the other variables under study.  45 
Conclusions In conclusion, the consumption of the WB drink for six weeks significantly reduced the levels of 46 
oxidized DNA bases and increased the resistance to oxidatively induced DNA damage. Future studies should 47 
address in greater detail the role of WB on endothelial function. This study was registered at www.isrctn.org as 48 
ISRCTN47732406. 49 
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Introduction   53 
Dietary habits and lifestyle in general are major risk and/or protective factors in the development and 54 
progression of degenerative diseases. The incidence of cardiovascular disease (CVD) as well as the prevalence 55 
of the metabolic syndrome is increasing world-wide 1. As a consequence, costs for health care are rising and 56 
there is a strong demand for preventive strategies that can be easily implemented by the majority of the 57 
population. Diets rich in fruits and vegetables are among the recommended lifestyle modifications to decrease 58 
the risk of CVD, but they can also reduce the complications associated with aberrant metabolic states or already 59 
established disorders 2. There is increased interest in the nutritional and functional aspects of berries (e.g. 60 
blackberry, bilberry, blackcurrant, cranberry, strawberry and blueberry) that can be consumed as fresh or 61 
processed foods 3-5. They contain high amounts of flavonoids and phenolic acids that may be important 62 
components for the biological processes 6-7. Wild or lowbush blueberries (Vaccinium angustifolium) are a rich 63 
source of anthocyanins (ACNs) that have high antioxidant capacity as demonstrated in vitro, in the animal model 64 
and in humans 8-10. ACNs have been demonstrated to positively affect inflammation, hyperglycemia, lipid 65 
metabolism, fat deposition, endothelial function, and to decrease the oxidative damage of macromolecules 11-66 
18. However, the study of the mechanisms by which wild blueberries contribute to the beneficial health effects 67 
remains quite difficult since ACNs are poorly absorbed (within 1-3h), and are rapidly metabolized and excreted 68 
(within 12-24 h) after consumption 19. 69 
The protective effect of wild blueberry intake has been studied in several animal models in our laboratories 12; 70 
20-25. In particular, we demonstrated that the intake of wild blueberries (24 mg ACNs per day) can improve 71 
vasomotor tone in the rat aorta and lymphocyte resistance against oxidatively induced DNA damage 21-22. 72 
However, it is important to validate the observations from animal experimental models with controlled human 73 
interventions to determine the protective effect of wild blueberries on a wide range of biomarkers especially in 74 
subjects with CVD risk. To our knowledge there is a paucity of studies that have evaluated the in vivo effect of 75 
blueberry consumption in humans with risk factors for CVD 16; 26. The aim of the present human intervention 76 
study was to investigate the hypothesis that regular intake of a wild blueberry drink for 6 weeks could improve 77 
peripheral endothelial function (measured by reactive hyperemia arterial tonometry), biomarkers of oxidative 78 
stress (e.g. DNA damage and repair), lipid profile, and inflammatory markers in subjects with at least one risk 79 
factor for CVD.   80 
 81 
 82 
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 Materials and Methods 83 
Recruitment of subjects 84 
Subjects involved in the study were recruited from the staff of the University of Milan and other Institutes 85 
through advertisement on bulletin boards. Only male subjects were included in the study in order to avoid effects 86 
related to hormonal fluctuation during the various phases of the menstrual cycle 27. Inclusion criteria were: 87 
healthy subjects with at least one risk factor for CVD (based on American Heart Association guidelines 28) 88 
such as: pre-hypertension (systolic pressure 120-139 mm Hg and diastolic pressure between 80-89 mm Hg), high 89 
serum cholesterol (≥5.17 mmol/L), low high density lipoprotein (HDL)-cholesterol (<1.03 mmol/L), high low 90 
density lipoprotein (LDL)-cholesterol (≥3.36 mmol/L), high triglycerides (≥1.69 mmol/L) overweight (BMI ≥25 91 
kg/m2) and smoking (>10 cigarettes/day). Individuals with secondary hypertension or obesity (BMI ≥30) were 92 
excluded. A medical history questionnaire was used to exclude subjects with clinical diseases such as diabetes, 93 
renal insufficiency, known food allergic reactions, chronic constipation, diarrhea or any other gastrointestinal 94 
problem or disease. Subjects were specifically excluded from the study if they were taking drugs, supplements, 95 
specific probiotics or medications during the last month before the beginning of the experiment. Weight and 96 
height were assessed and subjects were selected on the basis of an interview to evaluate their dietary habits and 97 
ensure that they were as homogeneous as possible, in particular for fruit and vegetables consumption. This was 98 
obtained by means of a food frequency questionnaire previously published and specifically revised to focus on 99 
food sources rich in antioxidants 29. Other exclusion criteria were: high (> 5 portions/day) or low (<2 100 
portions/day) intake of fruit and vegetables and habitual alcohol consumption (< 3 drinks per week were 101 
tolerated). Volunteers who followed a specific diet such as vegetarian, vegan or macrobiotic, and those who had 102 
a specific aversion to blueberries or their products were excluded. Twenty male subjects, ages 47.8  9.7 years 103 
with body mass index (BMI) 24.8  2.6 kg/m2 were selected. The study was performed in accordance with the 104 
ethical standards laid down in the 1964 Declaration of Helsinki and approved by the Ethics Committee of the 105 
University of Milan. All participants signed informed consent form. 106 
Blueberry and placebo drink preparation 107 
The wild blueberry (WB) drink was prepared by suspending 25 g of WB freeze-dried powder (i.e. a composite 108 
from Wayman’s (Cherryfield, ME), standardized at 1.5% total ACNs by FutureCeuticals, (Momence, IL, USA)) 109 
in 250 ml of water to give an amount of WB equivalent to 1 cup of raw fruits (148 g, providing approximately 110 
375 mg of ACNs). The nutritional composition of the soluble WB powder used in the study is reported in Table 111 
1. The placebo (PL) drink was prepared to have sensory characteristics similar to the WB drink but it did not 112 
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contain polyphenols. The PL drink consisted of 250 mL water, 7.5 g fructose, 7 g glucose, 0.5 g citric acid, and 113 
0.03 g blueberry flavor (Kerry Ingredients & Flavours Italia S.p.A., Bergamo, Italy). In order to reach the same 114 
color, small amounts of food colors typically used by food industry for the production of sweetened soft drinks 115 
were added to the PL drink. The microbiological and chemical stability of the two drinks was evaluated. 116 
Microbiological stability was ensured for 72 h. Analysis of ACNs documented that their content in the WB drink 117 
decreased by about 20% after 24 h and by about 35% after 48 h at 4°C.  118 
Experimental design 119 
A randomized, repeated measures crossover design was utilized. Subjects were randomly divided (by using a 120 
computer random number generator) into two groups of ten subjects each: group 1 was assigned to the sequence 121 
WB drink/wash-out/PL drink, whereas group 2 followed the sequence PL drink/wash-out/WB drink. WB and PL 122 
drinks were consumed daily for 6 weeks; the two treatments were separated by a 6 week wash-out period. 123 
Subjects received each morning the freshly prepared WB or PL drink in appropriate iceboxes. Participants were 124 
instructed to keep the drink under refrigeration and to avoid exposing it to a heat source or light and consume the 125 
drink within the morning. Additionally participants were asked to mix the beverage very well before drinking, 126 
rinse out each bottle with water and drink it to ensure complete intake of the WB powder. Every Friday, subjects 127 
received the drinks for the week-end and kept them refrigerated. Subjects were instructed to maintain their 128 
normal dietary and lifestyle habits (as declared before enrollment) but to abstain from consuming berries and 129 
other ACN-rich food sources. For this reason, during the experimental period, each subject received a complete 130 
list of foods high in ACNs to be avoided. A 24 h record of food consumption was kept by each volunteer one 131 
day before blood collection to check compliance to the dietary instructions. Moreover a 3-day food record and a 132 
weekly direct interview were scheduled randomly during the two experimental periods. At the beginning and at 133 
the end of each treatment period, fasting venous blood samples were collected early in the morning after an 134 
overnight fast.  135 
Variables  136 
The improvement of endothelium-dependent vasodilation (measured by a non-invasive plethysmographic 137 
method), the reduction of oxidized purines and the improvement of cell resistance to H2O2-induced DNA 138 
damage (evaluated in mononuclear blood cells by the comet assay) were considered as the primary endpoints. 139 
The other variables under study were: nutritional biomarkers (ACNs, vitamin C, folate, vitamin B12, reduced 140 
glutathione (GSH), oxidized glutathione (GSSG)), lipid profile (triglycerides, total cholesterol, LDL and HDL-141 
cholesterol), glucose, markers of inflammation (interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), C-reactive 142 
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protein (CRP),  soluble vascular adhesion molecule (s-VCAM-1), total nitric oxide (NO), augmentation index 143 
(AI), augmentation index standardized for heart rate of 75 bpm (AI@75), blood pressure, DNA repair activity, 144 
enzymes activity (glutathione S-transferase activity (GST), superoxide dismutase (SOD) and glutathione 145 
peroxidase (GSH-Px), serum creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and 146 
gamma-glutamyltransferase (GGT). 147 
 148 
Anthocyanin and phenolic acids extraction and analysis in the wild blueberry powder by LC-DAD-149 
MS/MS 150 
The Liquid Chromatography-diode array detector-mass spectrometry (LC-DAD-MS/MS) analysis of ACNs in 151 
the WB powder was performed in accordance to a procedure previously published 20. Briefly, the WB powder 152 
(250 g) was suspended in 1% trifluoroacetic acid (TFA) aqueous solution, and extraction was performed through 153 
sonication. After centrifugation the supernatant was injected in the LC system for the analysis. Phenolic acids 154 
were extracted as previously described. The High Performance Liquid Chromatography (HPLC) analysis was 155 
performed with a system equipped with an Alliance mod 2695 (Waters, Milford, MI, USA) and a mod 2996 156 
photo diode array detector (Waters). Chromatographic data were acquired using an Empower workstation 157 
(Waters). The analytical column was a 5μm C18 Vydac 201TP54 (250mm×4.6mm, i.d.; Esperia, CA, USA) with 158 
biocompatible frits. The eluents were (A) phosphoric acid (0.1%) and (B) 159 
methanol/acetonitrile/water/phosphoric acid (22.5/22.5/55/0.1) at a flow rate of 1.5 mL/min. The calibration 160 
curves were in the range of 1-10 μg/mL. Visible detection was achieved at 320 nm. 161 
 162 
Soluble and insoluble fiber analysis in the wild blueberry powder. 163 
Soluble and insoluble dietary fiber in the WB powder was determined by the AOAC (Association of Official 164 
Analytical Chemists) International method 991.43; an AACC (American Association for Clinical Chemistry) 165 
46.13 for the protein in the residue was used 30. 166 
 167 
Sample collection and separation 168 
Blood was collected early in the morning by a phlebotomist. Samples were drawn into evacuated tubes with or 169 
without heparin. Plasma was separated within 30 min after collection while serum within 1 h, by centrifugation 170 
for 15 min at 2300 x g at 4°C. Mononuclear blood cells (MNBC) were obtained from whole blood by density 171 
gradient centrifugation with Histopaque 1077 (Sigma Chemicals Co., St. Louis, MO). Mononuclear blood cells 172 
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were removed from the gradient, washed with Phosphate Buffer Saline (PBS) and used for the determination of 173 
endogenous and cell resistance to H2O2-induced DNA damage. An aliquot of MNBC was isolated and dissolved 174 
into an appropriate medium (90% RPMI media, 10% Dimethyl sulphoxide, Sigma) and stored at -80°C until 175 
evaluation of repair activity. Red blood cells were obtained from whole blood by centrifugation at 2300 x g for 176 
10 min and were washed with an equal volume of PBS solution. Red blood cells (1 mL) were diluted with iced 177 
water (1:4) and centrifuged at 10000 x g for 10 min. All samples were then aliquoted, stored at -80°C until 178 
determination of hemoglobin and evaluation of SOD and GSH-Px activities. Red blood cells (500 μL) used for 179 
glutathione analysis were acidified with an equal solution of metaphosphoric acid (10%) before storage. 180 
Analysis of biochemical parameters 181 
A general laboratory biochemical assessment was performed including evaluation of hepatic and renal function 182 
(serum creatinine, AST, ALT and GGT), lipid profile (triglycerides, total cholesterol, and HDL-cholesterol) and 183 
glucose 31. All these parameters were determined using standard laboratory methods. LDL cholesterol was 184 
calculated using the Friedewald’s method. Plasma IL-6, TNF-α, CRP and s-VCAM 1 concentrations were 185 
measured by Quantikine human colorimetric sandwich ELISA immunoassay kits (R&D Systems, Inc. 186 
Minneapolis, MN). Plasma concentration of total NO was calculated by measuring the products of oxidation 187 
(nitrate and nitrite) by a Fluorometric Assay Kit (Cayman Chemical, Ann Arbor, MI). Lymphocyte GST activity 188 
analysis was performed in accordance to the procedure described previously 32. GST activity was standardized 189 
to milligrams of protein and determined using a BCATM Protein Assay Kit (Pierce, Rockford, IL, USA). SOD 190 
and GSH-Px activities were measured in erythrocytes using commercial kits (Cayman chemical, Ann Arbor, 191 
USA). Enzyme activities were standardized to milligrams of hemoglobin determined by the use of the Drabkins 192 
reagent (Sigma Diagnostic, Co., St. Louis, MO). Vitamin C was determined in plasma by HPLC analysis as 193 
previously published 18. Vitamin B12 and total folate were measured by competitive immunoassay using direct 194 
chemiluminescence 31. Analysis of GSH and GSSG in the erythrocyte lysate was performed following the 195 
instructions reported in a commercially available kit (Cayman chemical, Ann Arbor, USA).  196 
 197 
Anthocyanin extraction and analysis in plasma 198 
Two aliquots of plasma (1 mL) were acidified with TFA (1%), vortexed, and centrifuged for 1 min at 4500 x g 199 
and the supernatant was stored at -80°C until analysis. Anthocyanins were extracted from plasma using a Micro-200 
Plate solid phase extraction (SPE) HLB Oasys Cartridge preactivated with methanol (500 μL) and washed with 201 
500 μL acidified water (1% TFA). Plasma (400 μL) was diluted with 140 μL of acidified water (1% TFA) and 60 202 
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μL of water containing the Internal Standard (50 ng/ml of CydG). Plasma was vortexed, centrifuged and loaded 203 
onto the cartridge. The samples were drained under gravity and the cartridge washed with acidified water (100 204 
μL; 1% TFA) and 100 μL acidified MetOH (20% TFA). The ACNs were eluted from the cartridge using 50 μL 205 
of methanol (70%) containing TFA. The filtered sample was injected into UHPLC MS/MS system for analysis 206 
according to a method previously published 20.  207 
 208 
Evaluation of peripheral vasoreactivity  209 
Evaluation of peripheral vasoreactivity was performed before blood drawing to avoid possible side effects on 210 
blood pressure and vasoactivity. Endothelial-dependent vasodilation in the small finger arteries was assessed by 211 
a non-invasive plethysmographic method (Endo-PAT2000, Itamar Medical Ltd., Caesarea, Israel) based on the 212 
registration of pulsatile blood volume in the fingertips of both hands. The Endo-PAT equipment consists of two 213 
finger-mounted probes, which include a system of inflatable latex air-cushions within a rigid external case; 214 
pulsatile volume changes of the fingertip are sensed by a pressure transducer, located at the end of each probe, 215 
and transferred to a personal computer where the signal is band pass-filtered (0.3 to 30 Hz), amplified, displayed, 216 
and stored. The Endo-PAT studies were performed with the patient in the supine position and both hands on the 217 
same level in a comfortable, thermoneutral environment. Arterial systolic and diastolic blood pressure and heart 218 
rate frequency were measured before starting the test. A blood pressure cuff was placed on one upper arm (study 219 
arm), while the contralateral arm served as a control (control arm). After a 10-min equilibration period, the blood 220 
pressure cuff on the study arm was inflated to 60 mmHg above systolic pressure for 5 min. The cuff was then 221 
deflated to induce reactive hyperemia (RH) whereas the signals from both PAT channels (Probe 1 and Probe 2) 222 
were recorded by a computer. The Reactive Hyperemia Index (RHI), an index of the endothelial-dependent flow-223 
mediated dilation (FMD), was derived automatically in an operator independent manner, as the ratio of the 224 
average pulse wave amplitude during hyperaemia (60 to 120 s of the post-occlusion period) to the average pulse 225 
wave amplitude during baseline in the occluded hand divided by the same values in the control hand and then 226 
multiplied by a baseline correction factor. A RHI value of 1.67 provides a sensitivity of 82% and a specificity of 227 
77% to diagnosing endothelial dysfunction 33. RHI has been shown to correlate with the ischemia-induced 228 
FMD in the larger brachial artery measured by high resolution ultrasound and with the gold standard method (the 229 
acetylcholine infusion in coronary arteries) for the endothelial function assessment 34-35.  230 
In addition to the RHI we have also reported in our paper the Framingham RHI (FRHI), which was automatically 231 
calculated using, however, a different post-occlusion hyperaemia period (90 to 120 s) without baseline correction 232 
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factor. The FRHI, that has been shown to correlate with other CVD risk markers 36, 37, was expressed as 233 
natural log of the resulting ratio.  234 
Finally, the EndoPAT device also generates the Augmentation Index (AI), a measure of vascular stiffness (pulse 235 
wave reflection) that is calculated from the shape of the pulse wave recorded by the probes during baseline. AI 236 
can be adjusted to a heart rate of 75 beats/min to correct for the independent effect of heart rate on this measure 237 
38.  238 
Evaluation of DNA damage, repair activity and cell resistance against H2O2-induced DNA damage 239 
 The level of oxidized bases was determined as formamidopyrimidine DNA glycosylase (FPG) sensitive sites in 240 
MNBCs by the comet assay as described previously 39. The FPG protein detects 8-oxo-7,8-dihydro-2’-241 
deoxyguanosine (8-oxodG) and ring-opened formamidopyrimidine nucleobases. This analysis of oxidatively 242 
damaged DNA has been thoroughly validated in inter-laboratory validation trials and shows generally good 243 
concentration-response relationship with agents that preferentially generate 8-oxodG 40-41. The repair activity 244 
toward oxidatively damaged DNA was measured by the comet assay in substrate A549 cells treated with 1 μM 245 
Ro19-8022/white light, which generates 8-oxo-7,8-dihydroguanine. Cell extracts were incubated with substrate 246 
cells for 20 min at 37°C 42. We measured the cell resistance against oxidatively-generated DNA damage (i.e. 247 
strand breaks and alkali labile sites) in freshly isolated MNBCs treated with H2O2 (500 μmol/L in PBS) for 5 min 248 
as described previously 43. The levels of DNA damage were calculated as percentage of DNA in tail. For each 249 
sample, the percentage DNA in tail of control cells (not treated with H2O2 or not incubated with FPG) was 250 
subtracted from the percentage DNA in tail of H2O2-treated or FPG incubated cells, respectively. 251 
 252 
Statistical analysis  253 
Sample size has been calculated taking into account the expected variation in the primary endpoints considered. 254 
In particular twenty subjects were calculated to be sufficient to evaluate a difference of RHI after WB drink of 255 
0.28 (standard deviation 0.40), with alpha=0.05 and a statistical power of 80%. Moreover, the "repeated 256 
measure" experimental design in which each subject acts as its own control, allows to conduct experiment more 257 
efficiently reducing the error variance.  258 
Statistical analysis was performed by means of STATISTICA software (Statsoft Inc., Tulsa, OK, US). The 259 
Shapiro-Wilk test was applied to verify the normal distribution of the variables. Data obtained were examined by 260 
analysis of variance (ANOVA) with the treatment sequence (WB drink vs PL drink or vice versa) as the 261 
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independent factor in order to exclude the presence of carry-over effects. As none was detected, data were 262 
analyzed by ANOVA for repeated measures design. ANOVA with treatment (WB drink vs PL drink) and time 263 
(before and after each treatment) as dependent factors was applied to evaluate the effect of the WB drink on the 264 
variables under study. The difference in responses to the WB and PL drink periods was evaluated by statistically 265 
significant P-values for the interaction between treatment and time in the overall repeated ANOVA. Moreover, 266 
ANOVA with type of treatment as the dependent factor was used to evaluate percentage change (i.e. [after 267 
treatment-before treatment]/ before treatment *100) at the different endpoints of peripheral arterial function. The 268 
mean changes are described as mean with 95% confidence interval (CI). Differences are considered significant at 269 
p ≤ 0.05; post-hoc analysis of differences between treatments was assessed by the Least Significant Difference 270 
(LSD) test with p ≤ 0.05 as level of statistical significance. Finally, a statistical analysis of data on peripheral 271 
arterial function and DNA damage was performed by considering a stratification according to the number of risk 272 
factors in the subjects enrolled. In particular two classes were considered: class 1 (subjects with  2 risk factors) 273 
and class 2 (subjects with >2 risk factors).   274 
RESULTS 275 
Composition and characteristics of the wild blueberry powder 276 
The nutritional composition of the WB powder used for the study expressed for 100 g of product and 25 g (one 277 
portion) are reported in Table 1. One portion of the WB powder provided about 102 kcal, 1.5 g of lipids, 1 g of 278 
proteins, 17 g of sugars (glucose and fructose) and 4.2 g of total fiber. The soluble and insoluble fiber was 0.6 g 279 
and 3.6 g, respectively. Chlorogenic acid (127.5 mg / 25 g) was the main phenolic acid detected in the WB 280 
powder. The total ACN concentration was 375 mg / 25 g with peonidin-3-glucoside, malvidin-3-galactoside, 281 
delphinidin-3-glucoside and delphinidin-3-galactoside as the dominant ACN compounds which represented 282 
about 35% of the total amount of ACNs as previously reported 20. 283 
Baseline characteristics of the subjects 284 
Twenty people began the study and eighteen completed the whole protocol. Two subjects withdrew from the 285 
study due to personal reasons. Baseline anthropometric and clinical characteristics of the remaining 18 subjects 286 
are available in Table 2. Blood pressure, lipid profile and inflammatory markers were within the range of 287 
normality. According to the guidelines of the American Heart Association (28), 8 subjects were classified as 288 
overweight (BMI  25 kg/m2), 7 had high levels of total cholesterol (6.2 mmol/L) and 7 borderline high (5.17-289 
6.18 mmol/L). Six subjects had high levels of LDL-cholesterol (4.13 mmol/L) and 7 were borderline high 290 
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(3.36-4.11 mmol/L). Ten subjects were pre-hypertensive (systolic pressure 120-139 mm Hg and diastolic 291 
pressure between 80-89 mm Hg). Nine subjects were smokers/ex-smokers. Finally eight subjects had below 292 
normal endothelium-dependent vasodilation with a RHI value ≤ 1.67.  293 
Effect of intervention on dietary markers 294 
The effect of the 6 week intervention with the WB vs the PL drink on dietary markers evaluated in plasma is 295 
reported in Table 3. The intervention resulted in no significant effect on vitamin C, vitamin B12, folate, GSH and 296 
GSSG concentrations and GSH/GSSG ratio. No ACNs were detected in the plasma after the WB or PL drink 297 
treatment after 6 weeks of intervention.  298 
Effect of intervention on vascular function and blood pressure 299 
The values of RHI, FRHI, AI, AI@75, NO, sVCAM-1 and blood pressure are reported in Table 4. One subject 300 
was omitted from the analysis due to abnormal values registered in 2 different time points. Vascular function of 301 
the subjects measured by Endo-PAT2000 did not improve significantly, according to the repeated measures 302 
ANOVA, after the WB and PL drinks (P=0.452 for the interaction between treatment and time). However, an 303 
apparent decrease in the RHI was observed during consumption of the PL drink with respect to WB drink. The 304 
mean percent change between the pre-to-post intervention was +4.9% (95%CI: -11%, +20.8%) after the WB 305 
drink and -4.9% (95%CI: -12.6%, +3.9%) after the PL drink. On the whole a high inter-individual variability 306 
was observed in the percent change of RHI (Figure 1) with about half of the subjects (53%; 9 out of 17) having 307 
an improvement following the intervention with the WB drink while the other half experienced (47%; 8 out of 308 
17) a decrease. In the placebo group we observed that few subjects (23%; 4 out of 17) had an improvement 309 
following the intervention with the PL drink, while more than a half of the subjects (59%; 10 out of 17) showed 310 
a decrease. The remaining subjects (18%; 3 out of 17) did not show any effect. No significant changes in FRHI, 311 
AI, AI@75, blood pressure (systolic and diastolic), total plasma NO and sVCAM-1 were documented after the 312 
6-week intervention with the WB drink or the PL drink.  313 
 314 
Effect of intervention on DNA damage and repair activity in blood mononuclear cells 315 
Results on the levels of DNA damage and repair activity are shown in Table 5. There was a significant different 316 
treatment effect between the WB and PL drink periods (P=0.039 for the interaction between treatment and time). 317 
Estimation of oxidized purines in MNBC DNA through quantification with the formamidopyrimidine DNA 318 
glycosylase (FPG)-sensitive sites indicated a statistically significant decrease following the WB drink (from 12.5 319 
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 5.6% to 9.6  3.5%, p0.01) with respect to the PL drink (from 12.0 ± 4.5% to 11.9 ± 4.4%, p=0.89). 320 
Moreover, there was also a different treatment effect between the WB and PL drink periods (P=0.037 for the 321 
interaction between treatment and time). The intake of the WB drink significantly decreased the levels of H2O2-322 
induced DNA damage (from 45.8  7.9% to 37.2  9.1%, p0.01), while no effect was observed after the PL 323 
drink (from 44.9 ± 12.2% to 44.4 ± 8.4%, p=0.84). Additionally, no significant effect was observed in DNA 324 
repair activity following the two treatments (WB vs PL drink).   325 
Effect of intervention on anthropometric measures and biochemical parameters  326 
Body weight, BMI and biochemical markers before and after the WB or PL drink are presented in Table 6. The 327 
intervention had no significant effect on body weight and BMI, glucose, creatinine and enzyme activity (AST, 328 
ALT and GGT) in liver and SOD and GSH-Px activity in erythrocytes, and GST activity in lymphocytes) of the 329 
subjects under study. No significant differences in lipid profile (triglycerides, total cholesterol, LDL and HDL 330 
cholesterol) were observed following WB drink consumption.  331 
  332 
Effect of intervention on biomarkers of inflammation 333 
The plasma levels of IL-6, TNF-α and CRP of the subjects before and after the WB and PL drink are reported in 334 
Table 7. No significant difference in inflammatory markers was detected as a result of the intervention.     335 
 336 
Effect of risk factor exposure on peripheral arterial function and levels of DNA damage 337 
Statistical analysis did not show differences in peripheral arterial function and levels of DNA damage before and 338 
after WB and PL drink depending on the number of risk factors identified in the subjects: class 1 (subjects with  339 
2 risk factors) and class 2 (subjects with >2 risk factors). When the subjects were classified as smokers/ex-340 
smokers vs. nonsmokers, we observed that the reduction in the levels of H2O2-induced DNA damage after the 341 
WB intervention was higher: smokers/ex-smokers (44.4 ± 7.7% vs 33.7 ± 5.9%, p≤0.01) with respect to the 342 
nonsmoker group (47.2 ± 8.3% vs 40.7 ± 10.7%, p=0.08) as indicated by the LSD test (data not shown). 343 
 344 
 345 
 346 
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DISCUSSION 347 
Most of the beneficial evidence on the modulation of endothelial function derives from experimental in 348 
vitro and ex vivo studies in which the vasoreactivity has been evaluated in the aorta of animals with invasive 349 
methods 12, 21-25, 44. The evaluation of the peripheral arterial function, as a marker of CVD risk, is a 350 
relatively new approach and only few human studies investigated the impact of polyphenol-rich foods on this 351 
parameter 45-48. Some studies have demonstrated an improvement in peripheral arterial function, through 352 
Endo-PAT 2000, after the ingestion of a single dose of polyphenol-rich foods, in particular flavonol-rich 353 
foods/beverages such as cocoa 45-47 and chocolate 48. The exploitation of Endo-PAT device to evaluate the 354 
long term effect of dietary interventions on vascular function merits further attention. To our knowledge, only 355 
one human intervention study investigated the effect of ACN-rich food on the modulation of endothelial function 356 
in a medium/long term intervention. Recently, Dohadwala et al. 49 demonstrated that 4 weeks of 357 
supplementation with cranberry juice (480 ml/day, providing 94 mg ACNs and 835 mg total polyphenols) had 358 
no effect on vascular function (measured by flow-mediated dilation in the brachial artery) in subjects with 359 
coronary artery disease. In the present study we have demonstrated no significant difference in the peripheral 360 
arterial function in subjects with CVD risk factors, with about half of the subjects exhibiting an improvement 361 
following the intervention with the WB drink. No significant difference was also observed in blood pressure, s-362 
VCAM-1 and total NO. The non-significant effect of the WB drink on the modulation of peripheral arterial 363 
function may be attributed to the kinetics of wild blueberry ACNs and/or other polyphenols. It is widely 364 
recognized that ACNs are rapidly cleared from plasma after an oral dose of berry fruits with maximum 365 
bioavailability between 1 and 3h 19. In our study, ACNs were non-detectable in plasma after WB consumption, 366 
since blood samples were taken 12h after the intake of the drink, when possibly ACNs were cleared from the 367 
circulation. However, many other factors may have affected our results such as: the large inter individual 368 
variation, individual differences in CVD risk factors, the duration of the intervention, and the amount and form 369 
of the WB product. We provided our subjects with a dietary daily amount of ACNs through the WB drink since 370 
we were interested in studying a realistic condition. Future studies with larger numbers of subjects with 371 
homogenous and/or more pronounced CVD risk factors or established endothelial dysfunction may show 372 
beneficial effect of blueberry intervention.  373 
The effects of berries on oxidative stress have been investigated in different human intervention studies, 374 
but results are still inconclusive. Results from intervention studies with berries (single berry items or mixture of 375 
different berries) have shown a reduction of the levels of oxidatively damaged DNA evaluated by means of the 376 
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comet assay 50-51, whereas there are studies showing no effect after ingestion of ACN-rich blackcurrant juice 377 
or an ACN drink 52. Under our experimental conditions, the WB drink reduced the level of oxidized DNA 378 
bases and increased the protection from the ex vivo H2O2 induced DNA damage. These results were particularly 379 
evident in the group of smokers/ex-smoker subjects with respect to nonsmokers. This effect on DNA damage 380 
may be dependent on phytochemicals present in WB drink that can exert a direct protective effect against 381 
oxidative insult by scavenging reactive oxygen species in blood. Moreover, ACNs may act through upregulation 382 
of the expression of different antioxidant genes involved in the detoxification of molecules such as hydrogen 383 
peroxide 53. Other processes that may have been modulated by the WB drink could be: alkylation or formation 384 
of ACN-DNA complexes, and/or modulation of DNA repair genes 54-55. In this regard, it has been reported 385 
that a flavonoid-rich diet could affect the expression of DNA repair genes belonging to different repair pathways 386 
like nucleotide excision repair, base excision repair and double strand breaks repair 55. In our study, 6 weeks 387 
of WB drink consumption did not show an increase in DNA repair activity. In addition no effect on SOD, GSH-388 
Px or GST activity was observed suggesting that upregulation of antioxidant enzymes is not the mechanism for 389 
the increased resistance toward H2O2-induced DNA damage. 390 
Studies on ingestion of polyphenol bioactive compounds have shown results on lipid profile data that 391 
are not univocal. Bilberries, blackcurrants, cranberry juice or extracts have shown a favorable effect on the lipid 392 
profile in dyslipidemic, hypercholesterolemic or metabolic syndrome subjects from improving HDL-cholesterol 393 
to lowering LDL-cholesterol and total triglycerides 56-59. On the contrary Basu et al. 16 reported that 8 394 
weeks of supplementation with a freeze dried blueberry beverage (50 g of powder, providing 742 mg of ACNs 395 
per day) did not change the plasma lipid profile in subjects with the metabolic syndrome. Similarly Stull et al. 396 
26 found that the consumption of two blueberry smoothies per day (45 g of freeze dried blueberry powder, 397 
providing 668 mg of ACNs) did not affect the lipid profile in obese subjects after 6 weeks of intervention. The 398 
above studies are in agreement with the present study, since the WB drink intervention did not alter the plasma 399 
lipid profile in subjects with risk factors for CVDs.  400 
The role of berries in decreasing markers of inflammation has not been well investigated and very few 401 
observations have shown an antinflammatory effect 26, 60. Our results do not show a significant effect of the 402 
WB drink intake on the plasma levels of IL-6, TNF-α and CRP. These results are in accordance with other 403 
observations reported in literature 16, 26, 60. It should be noted that the inflammatory markers in our 404 
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volunteers were in the normal physiologic concentration ranges at the onset of the study thus the potential of WB 405 
to affect such biomarkers maybe more appropriately evaluated on subjects with high initial levels. 406 
CONCLUSIONS 407 
In conclusion, consumption of a WB drink, providing 375 mg of ACNs, for 6 weeks reduced the level 408 
of oxidized purines and improved the resistance against H2O2-induced DNA damage in MNBCs. This indicates 409 
that regular consumption of wild blueberries can reduce oxidative stress in a relevant cell population in the 410 
blood, even though peripheral arterial function and the other variables studied here were not significantly 411 
affected. Future, larger studies are necessary to understand the duration of exposure to ACNs, the dose and/or the 412 
form of the WB product that may be effective in modulating endothelial function and the other parameters 413 
studied. 414 
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Legend 589 
 590 
 591 
Fig 1. Individual values of reactive hyperemia index (RHI) measured by Endo-PAT2000 (Itamar Medical Ltd., 592 
Caesarea, Israel) and registered before and after a six weeks WB drink and PL drink intake in the group of 593 
volunteers (n = 17).  WB, wild blueberry drink; PL, placebo drink 594 
 595 
596 
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Table 1 Composition of the wild blueberry powder drink.  597 
 
Nutritional composition                            One portion (25 g) 
Energy   (kcal)                                              101.8 
Total fat    (g)                                                    1.4 
    Saturated fat  (g)                                           0.2 
    Monounsatured fat  (g)                                 0.3 
    Polyunsatured fat  (g)                                   0.6 
Cholesterol (mg)                                               0 
Protein  (g)                                                       0.7 
Sugars  (g)                                                     17.1 
 Fiber      (g)*                                                   4.2       
              Soluble                                               0.6 
              Insoluble                                             3.6 
Anthocyanins (g)*                                            0.4  
Chlorogenic acid*                                         127.5 
Vitamin C (mg)                                                 4.2 
Folate  (mg)                                                     11.1 
 598 
Nutritional information was provided by FutureCeuticals Company. 599 
*The analysis was performed at our laboratory. 600 
 601 
 602 
 603 
 604 
 605 
 606 
 607 
 608 
 609 
 610 
 611 
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TABLE 2 Subject characteristics at the beginning of the study (n=18)1  613 
    
Variables  Value Variables Value 
Age (y) 47.8 ± 9.7 NO (μmol/L) 45.3 ± 7.3 
Body weight (kg) 75.7 ± 8.7 sVCAM-1 (ng/mL) 402 ± 116 
BMI (kg/m2) 24.8 ± 2.6 CRP (mg/dL) 0.19 ± 0.22 
Glucose (mmol/L) 4.9 ± 0.5 IL-6 (pg/mL) 2.1 ± 1.1 
Triglycerides (mmol/L) 1.2 ± 0.5 TNF-α (pg/mL) 3.4 ± 1.5 
Total cholesterol (mmol/L) 5.8 ± 1.2 Diastolic pressure (mm Hg) 79.4 ± 8.7 
LDL-cholesterol (mmol/L) 3.8 ± 1.0 Systolic pressure (mm Hg) 121 ± 16 
HDL-cholesterol (mmol/L)   1.4 ± 0.3 RHI 1.84 ± 0.46 
AST (U/L)  22.8 ± 4.8 FRHI 0.32 ± 0.27 
ALT (U/L) 26.7 ± 1.5 AI 5.22 ± 18.5 
GGT (U/L) 26.8 ± 10.7 AI@75 0.0 ± 17.4 
Creatinine (mmol/L) 
79.6 ± 8.8 H2O2-induced DNA damage (% DNA in 
tail) 
45.6 ± 10.1 
Anthocyanins (µmol/L) nd FPG sensitive sites (% DNA in tail) 13.4 ± 5.6 
Vitamin C (μmol/L) 63.1 ± 17.3 DNA repair activity (%DNA in tail) 6.5 ± 1.7 
Folate (nmol/L) 16.5 ± 4.5   
Vitamin B12 (pmol/L) 312 ± 110   
GSH (μmol/g Hb) 5.8 ± 1.0   
GSSG (μmol/g Hb) 0.65 ± 0.42   
GSH/GSSG ratio 11.2  4.53   
SOD activity (U/mg Hb) 4.7 ± 0.5   
GST activity (nmol/min/mg proteins) 35.1 ± 17.4   
GSH-Px activity (μmol /min/mg 
proteins) 
17.4 ± 7.3   
 614 
1Data are expressed as mean ± SD. BMI, body mass index; nd, not detectable; AST, aspartate aminotransferase; 615 
ALT, alanine aminotransferase; GGT, gamma-glutamyltransferase; GSH, reduced glutathione; GSSG, oxidized 616 
glutathione; SOD, superoxide dismutase; GST, glutathione S-transferase; GSH-Px, glutathione peroxidase; NO, 617 
nitric oxide; sVCAM-1, vascular cell adhesion molecule-1; CRP, C-reactive protein; IL-6, interleukin-6; TNF-α, 618 
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tumor necrosis factor alpha; RHI, reactive hyperemia index; FRHI, Framingham reactive hyperemia index; AI, 619 
augmentation index; AI@75, augmentation index standardized for heart rate of 75 bpm.  620 
 621 
 622 
 623 
TABLE 3 Effect of a 6-week intervention with the wild blueberry (WB) drink or placebo (PL) drink on 624 
nutritional biomarkers (n=18)1 625 
      
Variables Before WB 
Drink 
After WB 
Drink 
Before PL 
Drink 
After PL  
Drink 
P value2 
Anthocyanins (μmol/L) nd nd        nd nd - 
Vitamin C (µmol/L)  61.5  16.8 61.7  20.2 64.1  15.8 67.5  16.5 0.488 
Folate (nmol/L) 16.3  5.0 15.0  4.8 17.2  4.8 15.9  4.1 0.930 
Vitamin B12 (pmol/L) 308  92 298  99 314  107 322  105 0.392 
GSH (μmol/g Hb)  6.8  2.5 6.0  0.9 6.2  1.2 6.6  1.5 0.140 
GSSG (μmol/g Hb) 0.77  0.44 0.74  0.27 0.74  0.40 0.83  0.42 0.574 
GSH/GSSG ratio 11.25  6.58 8.99  2.98 9.03  3.74 9.45  4.62 0.216 
 626 
1 Data are expressed as mean ± SD. WB, wild blueberry; PL, placebo; nd, not detectable; GSH, reduced 627 
glutathione; GSSG, oxidized glutathione 628 
2P-values correspond to the interaction between treatment and time in the overall ANOVA (Statsoft Inc., Tulsa, 629 
OK, US).  630 
 631 
632 
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TABLE 4 Effect of a 6-week intervention with the wild blueberry (WB) drink or placebo (PL) drink on 633 
background and H2O2 induced strand breaks, FPG sensitive sites, DNA repair activity (n=18)1 634 
      
Variables  Before WB 
Drink 
After WB 
Drink 
Before PL 
Drink 
After PL 
Drink 
P value2 
Background SBs (% DNA in tail, 
EB) 
6.3  1.6 6.7  1.2 6.2  1.4 6.2  1.5 0.201 
Net FPG-sensitive sites (% DNA in 
tail) 
12.5  5.6 9.6  3.5* 12.0  4.5 11.9  4.4 0.039 
Background SBs (% DNA in tail, 
PBS) 
5.9  1.1 6.5  1.2 6.2  1.4 6.8  2.0 0.594 
Net H2O2-induced DNA damage 
(%DNA in tail) 
45.8  7.9 37.2  9.1* 44.9  12.2 44.4  8.4 0.037 
DNA repair activity (% DNA in 
tail)      
6.4  1.7 6.7  1.9 6.6  1.5 6.4  1.8 0.425 
 635 
1Data are expressed as meanSD. WB, wild blueberry; PL, placebo; SBs, strand breaks; PBS, phosphate buffer 636 
saline; EB, endonuclease buffer. *Significantly different from each other point, P≤0.05  637 
2P-values correspond to the interaction between treatment and time in the overall ANOVA (Statsoft Inc., Tulsa, 638 
OK, US).  639 
 640 
641 
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TABLE 5 Effect of a 6-week intervention with wild blueberry (WB) drink or placebo (PL) drink on vascular 642 
function, blood pressure, plasma total nitric oxide and soluble vascular cell adhesion molecule-1 (n=18)1 643 
      
Variables Before WB 
Drink 
After WB  
Drink 
Before PL 
Drink 
After PL 
Drink 
P value2 
RHI   1.83  0.43 1.86  0.55 1.87  0.48 1.76  0.41 0.452 
FRHI  0.35  0.28 0.29  0.33 0.34  0.31 0.30  0.25 0.838 
AI 3.57  15.6 3.18  14.9 6.94  17.5 4.71  16.5 0.407 
AI@75 -1.71  15.6 -3.76  14.1 0.00  17.9 0.47  16.3 0.458 
Diastolic pressure (mm Hg) 81.6  8.8 81.4  7.2 78.3  8.2 78.8  8.5 0.740 
Systolic pressure (mm Hg)  123  16 122  16 122  16 120  16 0.878 
Total NO (µmol/L)  48.5  24.1 49.8  23.6 45.9  16.9 43.7  20.2 0.666 
sVCAM-1 (ng/mL)  410  103 576  364 417  129 540  232 0.762 
 644 
1Data are expressed as meanSD; (n=17 vascular function). WB, wild blueberry; PL, placebo; RHI, reactive 645 
hyperemia index; FRHI, Framingham reactive hyperemia index; AI, augmentation index; AI@75, augmentation 646 
index standardized for heart rate of 75 bpm; Total NO, total nitric oxide; sVCAM-1, vascular cell adhesion 647 
molecules-1.  648 
2P-values correspond to the interaction between treatment and time in the overall ANOVA (Statsoft Inc., Tulsa, 649 
OK, US).  650 
 651 
652 
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TABLE 6 Effect of a 6-week intervention with the wild blueberry (WB) drink or placebo (PL) drink on 653 
anthropometric and biochemical characteristics of volunteers (n=18)1  654 
 655 
 656 
 657 
 658 
1Data are expressed as mean±SD. WB, wild blueberry; PL, placebo; BMI, body mass index; AST, aspartate 659 
aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyltransferase; SOD, superoxide 660 
dismutase; GSH-Px, glutathione peroxidise; GST, glutathione S-transferase.  661 
2P-values correspond to the interaction between treatment and time in the overall ANOVA (Statsoft Inc., Tulsa, 662 
OK, US).  663 
 664 
 665 
 666 
      
Variables Before WB 
Drink 
After WB 
Drink 
Before PL 
Drink 
After PL 
Drink 
P value2 
Body weight (kg) 75.9 ± 8.4 75.8 ± 8.7 76.2 ± 9.3 76.1 ± 9.3 0.977 
BMI (kg/m2) 24.9 ± 2.5 24.8 ± 2.6 24.9 ± 2.7 24.9 ± 2.6 0.977 
Glucose (mmol/L)  5.0 ± 0.5 5.0 ± 0.3 4.9 ± 0.6 5.0 ± 0.6 0.357 
Triglycerides (mmol/L)  1.3 ± 0.5 1.3 ± 0.5 1.3 ± 0.6 1.4 ± 0.6 0.279 
Total cholesterol (mmol/L) 5.9 ± 1.2 5.7 ± 1.3 5.9 ± 1.2 5.7 ± 1.3 0.774 
LDL-cholesterol (mmol/L)  3.9 ± 0.9 3.7 ± 1.0 3.8 ± 1.2 3.6 ± 1.0 0.726 
HDL- cholesterol (mmol/L)  1.4 ± 0.3 1.3 ± 0.2 1.4 ± 0.3 1.3 ± 0.3 0.241 
AST (U/L) 23.8 ± 8.1 23.3 ± 6.2 23.1 ± 4.8 23.8 ± 6.9 0.644 
ALT (U/L) 26.4 ± 10.7 27.5 ± 12.8 27.2 ± 12.1 27.5 ± 10.8 0.679 
GGT (U/L) 27.2 ± 11.0 26.5 ± 11.4 27.0 ± 10.7 25.3 ± 11.0 0.217 
Creatinine (mmol/L)  81.3 ± 11.5 82.2 ± 13.3 80.4 ± 10.7 80.4 ± 13.3 0.734 
SOD activity (U/mg Hb)  4.7 ± 1.3 4.4 ± 1.3 4.8 ± 1.3 4.5 ± 1.4 0.870 
GSH-Px activity (μmol/min/ml/g 
Hb)  
18.6 ± 9.5 18.0 ± 5.6 16.5 ± 5.6 19.4 ± 7.0 0.121 
GST activity (nmol/min/mg proteins)                                                                                                   25.9 ± 13.3 25.8 ± 9.6 31.4 ± 17.9 28.5 ± 11.0 0.672 
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TABLE 7 Effect of a 6-week intervention with the wild blueberry (WB) drink or placebo (PL) drink on 667 
circulating levels of interleukin 6, Tumor Necrosis Factor-α and C-reactive protein (n=18)1 668 
 669 
      
Variables Before WB 
Drink 
After WB 
 Drink 
Before PL  
Drink 
After PL 
 Drink 
P value2 
IL-6 (pg/mL)  2.1  1.4 2.1  0.9 2.4  1.3 1.9  1.0 0.303 
TNF-α  (pg/mL)  3.6  2.1 3.1  1.0 3.4  2.1 3.5  1.9 0.438 
CRP (mg/dL)  0.18  0.20 0.20  0.15 0.16  0.13 0.22  0.21 0.717 
 670 
1Data are expressed as meanSD. WB, wild blueberry; PL, placebo; IL-6, interleukin-6; TNF-α, tumor necrosis 671 
factor alpha; CRP, C-reactive protein.  672 
2P-values correspond to the interaction between treatment and time in the overall ANOVA (Statsoft Inc., Tulsa, 673 
OK, US).  674 
 675 
 676 
 677 
